PUBLISHER: Grand View Research | PRODUCT CODE: 2132487
PUBLISHER: Grand View Research | PRODUCT CODE: 2132487
The global medical robotic systems market size was valued at USD 16.7 billion in 2025 and is projected to grow from USD 20.3 billion in 2026 to USD 55.1 billion by 2033, at a CAGR of 15.3% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 46.6% in 2025. The industry is driven by the rising preference for minimally invasive procedures.
Market Concentration & Characteristics
The industry is marked by a high degree of innovation, driven by advancements in artificial intelligence, machine learning, and high-definition imaging technologies. These innovations enhance surgical precision, flexibility, and control, allowing for minimally invasive procedures with improved patient outcomes. Continuous research and development efforts are leading to more sophisticated, user-friendly robotic systems, expanding their application across various surgical specialties and boosting market growth. For instance, in April 2026, UC San Diego Health performed the West Coast's first AI robotic spine surgery using a new platform integrating AI, 3D imaging, patient-specific implants, navigation, and robotic screw delivery.
"This platform fundamentally changes how we think about spine surgery. For the first time, we are bringing together artificial intelligence, data-driven alignment planning, patient-specific implants, navigation, and robotic screw delivery within a single system. That level of precision and coordination allows us to operate more efficiently while significantly enhancing safety for our patients."
Joseph Osorio, MD, PhD, neurosurgeon at UC San Diego Health
The industry is witnessing a high level of mergers and acquisitions (M&A) activity. Major healthcare and technology companies are acquiring smaller, innovative firms to enhance their product portfolios and leverage advanced technologies. For instance, in July 2025, Zimmer Biomet announced a definitive agreement to acquire Monogram Technologies for approximately USD 177 million, aiming to expand its robotics portfolio with semi- and fully autonomous surgical technologies and strengthen its position in AI-enabled orthopedic robotics.
Regulations significantly impact the industry by ensuring safety, efficacy, and quality. Stringent approval processes by regulatory bodies such as the FDA and CE mark requirements can delay market entry, but also build trust and reliability. Compliance with these regulations demands substantial investment in research and development. However, successful navigation of regulatory frameworks enhances market credibility, encourages adoption by healthcare providers, and ultimately drives market growth.
Product expansion involves introducing new and advanced robotic solutions tailored to various surgical specialties. For instance, in April 2026, SS Innovations launched next-generation surgical robotic technologies, including the SSi Vimana Aero drone system and SSi Avtara humanoid platform, highlighting advancements in remote surgery, battlefield care, and mobile robotic operating environments at SMRSC 2026.
"Innovation is in our DNA. Beyond continuously improving our advanced, cost-effective SSi Mantra surgical robotic system and telesurgery capabilities, we strive to pioneer new surgical robotic technologies that will meaningfully improve healthcare for a wider segment of patients in need. SMRSC 2026, our largest conference yet, successfully elevated this important theme."
Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations
Global expansion is driven by increasing adoption in emerging economies, improved healthcare infrastructure, and supportive government policies. Companies are targeting regions like Asia-Pacific, Latin America, and the Middle East, leveraging local partnerships and investments to tap into growing demand and enhance their international market presence. For instance, in January 2026, American Hospital Dubai deployed the da Vinci 5 robotic surgical system, marking the region's first installation and expanding advanced robotic surgery capabilities, enabling enhanced surgical precision, improved tissue handling, and broader adoption of minimally invasive procedures.